About CPF Products & Services R&D News Contact Us
No.

Dosage

Strength

Indication
1 Relugolix Anhydrous Non-solvent Form 17-19kg
2 Remdesivir
3 Resmetirom Form I and Form λ 40-50 kg
4 Rimegepant Sulfate Form H1.5-1 8-12 kg
5 Rivaroxaban Form Ⅰ 140-150kg
6 Rosuvastatin Calcium Amorphous 205kg-225kg
7 Rosuvastatin Calcium Tablets 5mg/10mg/20mg/40mg Hypercholesterolemia
8 Ruxolitinib Phosphate As Innovator 14-17kg
1